生物
生发中心
淋巴细胞性脉络膜脑膜炎
染色质
调节器
细胞分化
重编程
PRC2
免疫系统
癌症研究
细胞生物学
CXCR5型
免疫疗法
T细胞
免疫学
获得性免疫系统
免疫
小RNA
染色质重塑
细胞
转录调控
癌症免疫疗法
基因表达调控
B细胞
辅活化剂
转录组
细胞命运测定
P300-CBP转录因子
作者
Jiaxi Song,Dan Cui,Jiabao Wang,Xuewei Qi,嘉欣 马,Haoyu Yu,Qing Liu,Jing Yang,Tengfei Hu,Han Xu,Handong Ma,Rentao Yu,Ying Dai,Xiaona Zhang,Qunfa Cao,Xiaoyuan Song,Bofeng Li,Lilin Ye,Hua Wang,Qizhao Huang
摘要
T follicular helper (TFH) cells are critical for humoral immunity against infections and correlate with immunotherapy efficacy, whereas immune checkpoint inhibitor therapy can drive their aberrant expansion, underscoring the need to understand the regulators controlling TFH cell fate. However, the epitranscriptomic regulation of their differentiation remains poorly understood. Here, we identify the 3-methylcytosine (m³C) methyltransferase METTL8 as a key regulator of TFH cell differentiation in both viral infection and cancer. METTL8 was preferentially expressed in CXCL13hi TFH cells, and its deficiency impaired TFH differentiation and germinal center responses in the lymphocytic choriomeningitis virus infection model and following anti-PD-1 immunotherapy in tumor models. Mechanistically, METTL8 exerted dual functions: it bound and stabilized Tcf7 mRNA through m³C modification, and it interacted with TCF1 protein to regulate chromatin accessibility and 3D genome organization at key TFH-associated loci, including Cxcr5 and Il6ra. Notably, ginkgolic acid treatment suppressed TFH responses without compromising the antitumor efficacy of anti-PD-1 therapy, an effect associated with METTL8. Collectively, our findings identify METTL8 as an epitranscriptomic regulator linked to RNA modification, TCF1-associated transcriptional control, and chromatin architecture during TFH differentiation and suggest that modulation of this pathway may provide a strategy to tune TFH-driven immune responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI